Journal of Neural Transmission

, Volume 104, Issue 10, pp 993–1004

Long-term modulation of presynaptic 5-HT-output: Experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density

  • G. Huether
  • D. Zhou
  • E. Rüther
Special Issue: Serotonin — Basic Research and Clinical Implications


Whereas experimentally induced long-term changes of postsynaptic mechanisms of 5-HT neurotransmission have been studied in great detail, much less is currently known about the effects of certain treatments on the presynaptic components governing the output of 5-HT in individual brain regions. This contribution summarizes the results of a series of experiments on the influence of different physiologic and pharmacologic manipulations on three different parameters of 5-HT presynapses, 5-HT transporter density, tryptophan hydroxylase content, and serotonin level in the rat frontal cortex. The combined measurement of several parameters of 5-HT presynapses allows to differentiate between treatments which exclusively affect the density of 5-HT transporters (long-term food restriction), which exclusively affect the level of tryptophan hydroxylase apoenzyme (imipramine treatment of olfactory bulbectomized rats) or which cause a parallel increase (bulbectomy, chronic administration of tranylcypramine to rats with chemical lesions of their cortical 5-HT innervation) or a parallel decrease (administration of p-chloroamphetamine) of both parameters, indicating treatment-induced changes in the density of 5-HT presynapses in the frontal cortex. Each of these changes may lead to an altered output of serotonergic afferences, and may therefore act to either potentiate or to attenuate the impact of serotonin-mediated effects on the activity of local networks located in a certain brain region.


[3H]-paroxetine-binding tryptophan hydroxylase serotonin (5-HT) 5-HT transporter 5-HT innervation food restriction bulbectomy amphetamines antidepressants presynaptic regulation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agren H, Reibring L (1994) PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27: 2–6Google Scholar
  2. Azmitia EC, Whitaker-Azmitia PM (1991) Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 52: 4–16Google Scholar
  3. Benkert O, Wetzel H, Szegedi A (1993) Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder. Int Clin Psychopharmacol 8: 3–14Google Scholar
  4. Bhattacharya SK, Glover V, McIntyre I, Oxenkrug G, Sandler M (1988) Stress causes an increase in endogenous monoamine oxidase inhibitor (tribulin) in rat brain. Neurosci Lett 92: 218–221Google Scholar
  5. Bjorklund A, Stenevi U (1979) Regeneration of monoamineergic and cholinergic neurons in the mammalian central nervous system. Physiol Rev 59: 62–100Google Scholar
  6. Bjorklund A, Nobin A, Stenevi U (1973) Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine. Brain Res 50: 214–220Google Scholar
  7. Bjorklund A, Wiklund L, Descarries L (1981) Regeneration and plasticity of central serotonergic neurons: a review. J Physiol 77: 247–255Google Scholar
  8. Borsini F (1994) Balance between cortical 5-HT1A and 5-HT2A receptor function: hypothesis for a faster antidepressant action. Pharmacol Res 30 (1): 1–11Google Scholar
  9. Cash CD, Vayer P, Mandel P, Maitre M (1985) Tryptophan 5-hydroxylase. Rapid purification from whole brain and production of a specific antiserum. Eur J Biochem 149: 239–245Google Scholar
  10. Chaput Y, De Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. Neuropsychopharmacology 5: 219–229Google Scholar
  11. Charney DS, Krystal JH, Delgado PL, Heninger GR (1990) Serotonin-specific drugs for anxiety and depressive disorders. Annu Rev Med 41: 437–446Google Scholar
  12. Dave V, Kimelberg HK (1994) Sodium-dependent, fluoxetine-sensitive serotonin uptake by astrocytes tissue-printed from rat cerebral cortex. J Neurosci 14: 4572–4986Google Scholar
  13. DeMontigny C, Blier P (1991) Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers. Arch Gen Psychiatry 48: 483–484Google Scholar
  14. DeMontigny C, Chaput Y, Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51: 4–8Google Scholar
  15. Edwards E, Kornrich W, v. Houtten P, Henn FA (1992) Presynaptic serotonin mechanisms in rats subjected to inescapable shock. Neuropharmacology 4: 323–330Google Scholar
  16. Fuller RW (1992) Basic advances in serotonin pharmacology. J Clin Psychiatry 53: 36–45Google Scholar
  17. Gardier AM, Malagie I, Trillat AC, Jacquot C, Artigas F (1996) Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10: 16–27Google Scholar
  18. Graham D, Tahroaoui L, Langer SZ (1987) Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-HT uptake inhibitors and [3H]-paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 26: 1087–1092Google Scholar
  19. Grecksch G, Zhou D, Franke C, Schröder U, Sabel B, Becker A, Huether G (1997) Influence of olfactory bulbectomy and subsequent imipramine treatment on serotonergic presynapses in the rat frontal cortex: behavioural correlates. Br J Pharmacol (in press)Google Scholar
  20. Hertz L (1989) Is Alzheimer's disease an anterograde neuronal-glial degeneration, originating in the brain stem, and disrupting metabolic and functional interactions between neurons and glial cells. Brain Res Rev 14: 335–353Google Scholar
  21. Huether G (1996) The central adaptation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain function. Prog Neurobiol 48: 569–612Google Scholar
  22. Huether G, Hajak G, Reimer A, Poeggeler B, Blömer M, Rodenbeck A, Rüther E (1992) The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacol 109: 422–432Google Scholar
  23. Huether G, Zhou D, Schmidt S, Wiltfang J, Rüther E (1997) Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex. Biol Psychiatry 41: 1174–1180Google Scholar
  24. Kuhn DM, Ruskin B, Lovenberg W (1980) Tryptophan hydroxylase: the role of oxygen, iron and sulfhydrylgroups as determinants of stability and catalytic activity. J Biol Chem 255: 4137–4143Google Scholar
  25. Kuikka JT, Tiihonen J, Bergström KA, Karhu J, Hartikainen P, Viinamäki H, Länsimies E, Lehtonen J, Hakola P (1995) Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 22: 346–350Google Scholar
  26. Lesch KP, Aulakh ChS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and ist regulation by uptake inhibiting antidepressants. Mol Brain Res 17: 31–35Google Scholar
  27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275Google Scholar
  28. Nakamura S (1990) Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex. Neurosci Lett 111: 64–68Google Scholar
  29. Nakamura S (1991) Effects of mianserin and fluoxetine on axonal regeneration of brain catecholamine neurons. Neuroreport 2: 525–528Google Scholar
  30. O'Connor WT, Leonard BE (1986) Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and ist enantiomers on behaviour and changes in noradrenaline metabolism of olfactory bulbectomized rats in the “open field” apparatus. Neuropharmacol 25: 267–270Google Scholar
  31. Risch SC, Nemeroff ChB (1992) Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psych 53: 3–7Google Scholar
  32. Seguela P, Watkins KC, Descarries L (1989) Ultrastructural relatinship of serotonin axon terminals in the cerebral cortex of the adult rat. J Comp Neurol 289: 129–142Google Scholar
  33. Siever LJ, Kahn RS, Laylor BA, Trestean RL, Lawrence TL, Coccaro EF (1991) Critical issues in defining the role of serotonin in psychiatric-disorders. Pharmacol Rev 43: 509–525Google Scholar
  34. Spoont MR (1992) Modulatory role of serotonin in neural information processing: implications für human psychopathology. Psychobiol Bull 112: 330–350Google Scholar
  35. Wetzler S, Kahn RS, Asnis GM, Korn M, VanPraag HM (1991) Serotonin receptor sensitivity and aggression. Psychiatry Res 37: 271–279Google Scholar
  36. Wiklund L, Mollgard K (1979) Neurotoxic destruction of the serotonergic innervation of the rat subcommissural organ is followed by reinnervation through collateral sprouting of non-monoaminergic neurous. J Neurocytol 10: 469–480Google Scholar
  37. Zhou D, Huether G, Wiltfang J, Hajak G, Rüther E (1996) Serotonin transporters in the rat frontal cortex: lack of circadian rhythmicity but down-regulation by food restriction. J Neurochem 67: 656–661Google Scholar
  38. Zhou D, Grecksch G, Backer A, Frank C, Pilz J, Huether G (1997) Serotonergic hyperinnervation of the frontal cortex in animal model of depression, the bulbectomized rat. Eur Arch Psychiatry Clin Neurosci (in press)Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • G. Huether
    • 1
  • D. Zhou
    • 1
  • E. Rüther
    • 1
  1. 1.Psychiatric ClinicUniversity of GöttingenGöttingenFederal Republic of Germany

Personalised recommendations